05/24/2026
The future of rare disease research is happening now. 🧠✨
This fascinating article highlights how organoids often called “mini brains in a dish” are transforming drug discovery and helping accelerate the development of lifesaving treatments. Scientists are increasingly using patient-derived organoids to better model human disease, test therapies faster, and reduce reliance on traditional animal models.
This is exactly why Cure CASK is investing in this space.
Through our “Mini Brains in a Dish” project and our collaboration with The University of Queensland and the CASK Coalition we are helping develop patient-derived brain organoids from individuals living with CASK disorders. These tiny lab-grown brain models allow researchers to study how specific CASK mutations affect brain development and function in ways never before possible.
Importantly, organoid technology is opening the door to more personalised approaches to treatment development something especially critical for rare neurological disorders like CASK.
Every family, donor, and researcher supporting this work is helping move the field closer to meaningful therapies and real hope for our children.
Organoids are miniature tissue or organ models formed by stem cells (including pluripotent stem cells, tissue-specific adult stem cells, etc.) or progenitor cells in an in vitro three-dimensional culture system, which possess structural features and partial functions analogous to their corresponding...
